Skip to main content
SpringerLink
Log in

The inflammatory response and tissue damage

The example of renal scars following acute renal infection

  • Invited Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Most clinical and experimental evidence suggests that renal scarring occurs following urinary tract infections in those patients with an abnormality of the urinary tract or kidney function. Experimentally, bacterial multiplication within the kidney occurs only in the presence of obstruction, leading rapidly to acute exudative pyelonephritis and invariably to kidney scars within weeks. Various manipulations of the bacterial load and/or of the inflammatory response during acute pyelonephritis have demonstrated that the inflammatory processes, not the bacterial component of pyelonephritis, are responsible for permanent renal tissue damage. Polymorphonuclear leucocytes (PMNLs) infiltrating the kidney tissue during acute pyelonephritis appear to release metabolites that are toxic to the parenchyma. Indeed, both the prevention of PMNL influx into renal tissue, by means of colchicine or cyclophosphamide, and the inactivation of some of their toxic metabolites, by means of dapsone, have led to the prevention of tissue damage and kidney scars. However, the most potent protective activity was observed with early antibiotic treatment, which stopped bacterial multiplication and prevented the early influx of PMNLs, thus preventing tissue damage and scar formation. Similar observations have been made in children with acute pyelonephritic episodes, in whom early and aggressive antibiotic treatment prevented subsequent kidney scars, while delayed treatment did not.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Angell ME, Relman AS, Robbins SL (1968) “Active” chronic pyelonephritis without evidence of bacterial infection. N Engl J Med 278:1303–1308

    PubMed  Google Scholar 

  2. Aoki S, Imamura S, Aoki M, McCabe WR (1969) “Abacterial” and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen. N Engl J Med 281: 1375–1382

    PubMed  Google Scholar 

  3. Kalmanson GM, Sommers SC, Guze LB (1965) Pyelonephritis. VII. Experimental ascending infection with progression of lesions in the absence of bacteria. Arch Pathol 80:509–516

    PubMed  Google Scholar 

  4. Glassock RJ, Kalmanson GM, Guze LB (1974) Pyelonephritis. XVIII. Effect of treatment on the pathology of enterococcal pyelonephritis in the rat. Am J Pathol 76: 49–60

    PubMed  Google Scholar 

  5. Guze LB, Kalmanson GM (1964) Persistence of bacteria in “protoplast” form after apparent cure of pyelonephritis in rats. Science 143:1340–1341

    Google Scholar 

  6. Strong DW, Lawson RK, Hodges CV (1974) Experimentally induced pyelonephritis using bacterial antigen and its prevention with immunosuppression. Invest Urol 11: 479–485

    PubMed  Google Scholar 

  7. Miller TE, North D (1971) The cellular kinetics of the immune response in pyelonephritis. J Lab Clin Med 78: 891–904

    PubMed  Google Scholar 

  8. Spencer AG, Fairhead AP (1972) The cellular immune response in experimentalEscherichia coli pyelonephritis in the rat. Nephron 9:325–336

    PubMed  Google Scholar 

  9. Kovats TG (1961) The role of endotoxin in autoimmune processes. Naturwissenschaften 49:572–573

    Google Scholar 

  10. Holmgren J, Hanson LA, Holm SE, Kaijser B (1971) An antigenic relationship between kidney and certainEscherichia coli strains. Int Arch Allergy Appl Immunol 41:463–474

    PubMed  Google Scholar 

  11. Kalmanson GM, Guze LB (1963) Pyelonephritis. An attempt to demonstrate anti-kidney antibody in the sera of patients with chronic bacteriuria. Am J Med Sci 246: 532–536

    PubMed  Google Scholar 

  12. Miller TE, Smith JW, Lehmann JW, Sanford JP (1970) Autoimmunity in chronic experimental pyelonephritis. J Infect Dis 122:191–195

    PubMed  Google Scholar 

  13. Coles GA, Chick S, Hopkins M, Ling R, Radford NJ (1974) The role of the T cell in experimental pyelonephritis. Clin Exp Immunol 16:629–636

    Google Scholar 

  14. Miller T, Burnham S, Simpson G (1975) Selective deficiency of thymus-derived lymphocytes in experimental pyelonephritis. Kidney Int 8:88–97

    PubMed  Google Scholar 

  15. Glauser MP, Lyons JM, Braude AI (1978) Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest 61:403–407

    PubMed  Google Scholar 

  16. Cotran RS (1969) Experimental pyelonephritis. In: Rouiller C, Muller AF (eds) The kidney: morphology, biochemistry, physiology, vol II. Academic Press, New York, pp 269–361

    Google Scholar 

  17. Mintter PM, Andriole VT (1985) Role of Tamm-Horsfall protein in the pathogenesis of reflux nephropathy and chronic pyelonephritis. Eur J Clin Microbiol 4:540–543

    PubMed  Google Scholar 

  18. Mayrer AR, Miniter P, Andriole VT (1983) Immunopathogenesis of chronic pyelonephritis. Am J Med 74: S59-S70

    Google Scholar 

  19. Mayrer AR, Kashgarian M, Ruddle NH, Marier R, Hodson CJ, Richards FF, Andriole VT (1982) Tubulointerstinal nephritis and immunologic responses to Tamm-Horsfall protein in rabbits challenged with homologous urine or Tamm-Horsfall protein. J Immunol 128:2634–2642

    PubMed  Google Scholar 

  20. Brooks SJD, Lyons JM, Braude AI (1974) Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascendingEscherichia coli pyelonephritis without bacteremia in rats. Am J Pathol 74: 345–354

    PubMed  Google Scholar 

  21. Brooks SJD, Lyons JM, Braude AI (1977) Immunization against pyelonephritis. III. Protection against chronicEscherichia coli pyelonephritis by vaccination. J Infect Dis 136:633–639

    PubMed  Google Scholar 

  22. Glauser MP, Francioli P, Bille J, Bonard M, Myelan P (1983) Effect of indomethacin on the incidence of experimentalEscherichia coli pyelonephritis. Infect Immun 40: 529–533

    PubMed  Google Scholar 

  23. Glauser MP, Lyons JM, Braude AI (1979) Synergism of ampicillin and gentamicin against obstructive pyelonephritis due toEscherichia coli in rats. J Infect Dis 139: 133–140

    PubMed  Google Scholar 

  24. Miller T, Phillips S (1981) Pyelonephritis: The relationship between infection, renal scarring, and antimicrobial therapy. Kidney Int 19:654–662

    PubMed  Google Scholar 

  25. Slotki IN, Asscher AW (1982) Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy. Nephron 30:262–268

    PubMed  Google Scholar 

  26. Ransley PG, Risdon RA (1981) Reflux nephropathy: effects of antimicrobial therapy on the evolution of the early pyelonephritic scar. Kidney Int 20:733–742

    PubMed  Google Scholar 

  27. Winberg J, Bergström T, Jacobsson B (1975) Morbidity, age and sex distribution, recurrences and renal scarring in symptomatic urinary tract infection in childhood. Kidney Int 8:S101-S106

    Google Scholar 

  28. Winter AL, Hardy BE, Alton DJ, Arbus GS, Churchill BM (1983) Acquired renal scars in children. J Urol 129: 1190–1194

    PubMed  Google Scholar 

  29. Westenfelder M, Galanos C (1974) Experimental lipid A-induced nephritis in the dog. A possible role of lipid A in the pathogenesis of abacterial chronic pyelonephritis. Infection 2:174–177

    PubMed  Google Scholar 

  30. Issekutz AC, Bhimji S (1982) Role for endotoxin in the leukocyte infiltration accompanyingEscherichia coli inflammation. Infect Immun 36:558–566

    PubMed  Google Scholar 

  31. Weissmann G, Smolen JE, Korchak HM (1980) Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 303:27–34

    PubMed  Google Scholar 

  32. Babior BM (1978) Oxygen-dependent microbial killing by phagocytes. N Engl J Med 298:659–669, 721–725

    PubMed  Google Scholar 

  33. McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159–163

    PubMed  Google Scholar 

  34. Bille J, Glauser MP (1982) Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effect of colchicine and neutropenia. J Infect Dis 146: 220–226

    PubMed  Google Scholar 

  35. Miller TE, Burnham S, North JDK (1976) Immunological enhancement in the pathogenesis of pyelonephritis. Clin Exp Immunol 24:336–345

    PubMed  Google Scholar 

  36. Sanford JP, Hunter BW, Donaldson P (1962) Localization and fate ofEscherichia coli in hematogenous pyelonephritis. J Exp Med 116:285–294

    PubMed  Google Scholar 

  37. Cotran RS (1963) Retrograde Proteus pyelonephritis in rats: localization of antigen and antibody in treated sterile pyelonephritic kidneys. J Exp Med 117:813–821

    PubMed  Google Scholar 

  38. Ivanyi B, Ormos J, Lantos J (1983) Tubulointerstitial inflammation, cast formation, and renal parenchymal damage in experimental pyelonephritis. Am J Pathol 113: 300–308

    PubMed  Google Scholar 

  39. Bradley PB, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–209

    PubMed  Google Scholar 

  40. Meylan P, Glauser MP (1984) Relationship between the polymorphonuclear leukocyte infiltration during acute exudative experimental pyelonephritis and the development of chronic pyelonephritis. Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, abstract 696

  41. Meylan PR, Bonard M, Glauser MP (1985) Effect of dexamethasone administered during acute exudative pyelonephritis on kidney scars in rats. Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, abstract 329

  42. Meylan PR, Glauser MP (1986) Effect of decomplementation and phenylbutazone on polymorphonuclear leukocytes infiltration during acute exudativeE. coli pyelonephritis. Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, abstract 1163

  43. Wilson DM, Ormrod DJ, Miller TE (1980) Role of complement in chemotaxis: study of a localized infection. Infect Immun 29:8–12

    PubMed  Google Scholar 

  44. Sullivan MJ, Harvey RA, Shimamura T (1977) The effects of cobra venom factor, an inhibitor of the complement system, on the sequence of morphological events in the rat kidney in experimental pyelonephritis. Yale J Biol Med 50:267–273

    PubMed  Google Scholar 

  45. Roberts JA, Roth JK, Domingue G, Lewis RW, Kaack B, Baskin G (1983) Immunology of pyelonephritis in the primate model. VI. Effect of complement depletion. J Urol 129:193–196

    PubMed  Google Scholar 

  46. Harber MJ, Topley N, Jenner DE, Mackenzie RK, Steadman R, Knowlden JM, Asscher AW (1986) Virulence factors of urinary pathogens in relation to kidney scarring. In: Asscher AW, Brumfitt W (eds) Microbial diseases in nephrology Wiley, New York, pp 69–82

    Google Scholar 

  47. Stendahl O, Molin L, Dahlgren C (1978) The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis. J Clin Invest 61:214–220

    Google Scholar 

  48. Meylan PR, Bille J, Glauser MP (1984) Protection against chronic pyelonephritis by dapsone administered during acute exudative pyelonephritis. Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, abstract 697

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, CH-1011, Lausanne, Switzerland

    M. P. Glauser, P. Meylan & J. Bille

Authors
  1. M. P. Glauser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Meylan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Bille
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by grant no. 3.836-81 and no. 3.950-84 from the Swiss National Foundation for Scientific Research

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glauser, M.P., Meylan, P. & Bille, J. The inflammatory response and tissue damage. Pediatr Nephrol 1, 615–622 (1987). https://doi.org/10.1007/BF00853599

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00853599

Key words

Search

Navigation